Academic Journal

Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
المؤلفون: Hernando Cubero, J., Grande, E., Jimenez Fonseca, P., Villabona, C., Trigo Perez, J.M., Martinez Trufero, J., Pajares Bernad, I., Lopez, C., Alonso, T., Biarnes, J., RamónY Cajal, T., Duran, M., Grau, J.J., Arevalo Lobera, S., Mesia Nin, R., Llanos, M., Dalmau Portulas, E., Alvarez, C., Zafon, C., Capdevila, J.
المصدر: Annals of Oncology ; volume 29, page viii476 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2018
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1093/annonc/mdy293.022
الاتاحة: http://dx.doi.org/10.1093/annonc/mdy293.022
https://api.elsevier.com/content/article/PII:S0923753419499444?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419499444?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy293.022/26139050/mdy293.022.pdf
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.C906DA4
قاعدة البيانات: BASE
الوصف
DOI:10.1093/annonc/mdy293.022